Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility.

Chia-Hung TsaiYu-Chin ChenPo-Yu ChenChih-Cheng LaiHung-Jen TangYin-Ching ChuangChi-Chung Chen Chung-Han HoWei-Yun HsuTu-Hsuan Chang

Published in: Infection and drug resistance (2023)

Prudent use of fluoroquinolones and ceftriaxone is advised when treating both CA and HA IAIs in the Asia-Pacific region. The low susceptibility rate of cefepime in India, Thailand, and Vietnam needs careful consideration in its administration. Moreover, the increase in nonsusceptibility to piperacillin/tazobactam in the Philippines and Taiwan poses a potential risk that should be closely monitored.

Keyphrases

gram negative
escherichia coli
pseudomonas aeruginosa
risk assessment
cystic fibrosis
climate change